AINI
Menu
Home
AINI
Statute
Steering Committee
Research Units
Codice di Condotta
Become a Member
Apply for Membership
Renewing Membership
All News
Focus on COVID-19
AINI Press Review
Video Interviews
Webinar
AINI Congresses
AINI Congress
AINI Winners
ESNI Courses
ISNI
CRNI Courses
Patronage
Altri Congressi
Utilities
General Guidelines
Standardizzazione Diagnostica Neuroimmunologica
AINI Guidelines
Job market
Links
Flow Cytometry
Imaging Software
AINI Laboratory Facilities
Travel Grants
Members Only
Library
Published by AINI Members
Slide AINIESNI 2017
Protocols
AINI CONGRESS
AINI CONGRESS
AINI CONGRESS
Home
AINI
Statute
Steering Committee
Research Units
Codice di Condotta
Become a Member
Apply for Membership
Renewing Membership
All News
Focus on COVID-19
AINI Press Review
Video Interviews
Webinar
AINI Congresses
AINI Congress
AINI Winners
ESNI Courses
ISNI
CRNI Courses
Patronage
Altri Congressi
Utilities
General Guidelines
Standardizzazione Diagnostica Neuroimmunologica
AINI Guidelines
Job market
Links
Flow Cytometry
Imaging Software
AINI Laboratory Facilities
Travel Grants
Members Only
Library
Published by AINI Members
Slide AINIESNI 2017
Protocols
Home
AINI
Statute
Steering Committee
Research Units
Codice di Condotta
Become a Member
Apply for Membership
Renewing Membership
All News
Focus on COVID-19
AINI Press Review
Video Interviews
Webinar
AINI Congresses
AINI Congress
AINI Winners
ESNI Courses
ISNI
CRNI Courses
Patronage
Altri Congressi
Utilities
General Guidelines
Standardizzazione Diagnostica Neuroimmunologica
AINI Guidelines
Job market
Links
Flow Cytometry
Imaging Software
AINI Laboratory Facilities
Travel Grants
Members Only
Library
Published by AINI Members
Slide AINIESNI 2017
Protocols
AINI CONGRESS
Menu
Home
AINI
Statute
Steering Committee
Research Units
Codice di Condotta
Become a Member
Apply for Membership
Renewing Membership
All News
Focus on COVID-19
AINI Press Review
Video Interviews
Webinar
AINI Congresses
AINI Congress
AINI Winners
ESNI Courses
ISNI
CRNI Courses
Patronage
Altri Congressi
Utilities
General Guidelines
Standardizzazione Diagnostica Neuroimmunologica
AINI Guidelines
Job market
Links
Flow Cytometry
Imaging Software
AINI Laboratory Facilities
Travel Grants
Members Only
Library
Published by AINI Members
Slide AINIESNI 2017
Protocols
News
IL-21 drives secondary autoimmunity in patients with multiple sclerosis, following therapeutic lymphocyte depletion with alemtuzumab (Campath-1H)
The following content is accessible for members only, please sign in.
Loading…
